Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 03-2017 | 02-2017 | 12-2016 | 11-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15 | N/A | N/A | N/A | 13 |
| TOTAL | $24 | $N/A | $N/A | $N/A | $13 |
| Non-Current Assets | |||||
| Intangibles | 14 | 0 | 0 | 0 | 14 |
| TOTAL | $14 | $N/A | $N/A | $N/A | $14 |
| Total Assets | $37 | $N/A | $N/A | $N/A | $27 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5 | 0 | 0 | 0 | 3 |
| TOTAL | $5 | $N/A | $N/A | $N/A | $3 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 3 | 0 | 2 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5 | $N/A | $N/A | $N/A | $3 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,275 | N/A | 2,272 | N/A | 2,253 |
| Common Shares | 23 | N/A | N/A | N/A | 23 |
| Retained earnings | -22,425 | N/A | N/A | N/A | -22,346 |
| TOTAL | $32 | $N/A | $N/A | $N/A | $24 |
| Total Liabilities And Equity | $38 | $0 | $0 | $0 | $27 |